Lifecycle Management Services

The opportunities arising from the fast growing Chinese pharmaceutical market are negatively impacted by constant and stringent healthcare reforms. These reforms focus on the reimbursement system, co-payment issues, pricing , tender and bidding systems, hospital listing regulations, intellectual property issues and license re-evaluations. To manage these complex issues we have created our unique lifecycle management organization consisting of highly interactive medical, regulatory, governmental affairs, and marketing experts, which tailor make lifecycle programs towards your Rx and OTC products needs.